TLX

Telix Pharmaceuticals
$9.98
−$0.24 (−2.35%)Jul 27, 2026
6.5GoodMoatMint rating

MoatMint rates Telix Pharmaceuticals (TLX) 6.5 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 8.0 out of 10.

Key metrics

The numbers that frame TLX today
Market cap
$3.38B
P/E (TTM)
-683.3
EV / FCF
-120.8
Gross margin
53.1%
EV / Sales
6.5
ROIC
5.5%
Div yield
0%
Debt / equity
1.1
52wk Low
$6.28
52wk High
$14.27

TLX stock rating

How TLX scores on quality, value, growth, momentum and financial health
6.5out of 10
Good overallHealthy business, full priceTop 35% of ~5,000 US stocks
QualityGreat8.0/10
GrowthNo scoren/a/10
MomentumNeutral5.8/10
ValueFair3.8/10
Financial HealthNo scoren/a/10

Growth

Revenue and earnings trend for TLX
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about TLX
Is Telix Pharmaceuticals a good buy?
Yes. Telix Pharmaceuticals has excellent quality and mixed momentum. Taken together, the setup leans positive. We think Telix Pharmaceuticals is selling at a high price, which cuts against the buy case.
What is the market capitalization of TLX?
Telix Pharmaceuticals's market capitalization is $3.38B.
What is the P/E ratio for TLX stock?
Telix Pharmaceuticals's current P/E ratio is -683.3.
What is the 52-week high for TLX stock?
The 52-week high for Telix Pharmaceuticals is $14.27. The current close of $9.98 is 30.1% below that high.
What is the 52-week low for TLX stock?
The 52-week low for Telix Pharmaceuticals is $6.28. The current close of $9.98 is 58.9% above that low.
Does TLX stock pay dividends?
Telix Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TLX?
Telix Pharmaceuticals's Debt / Equity ratio is 1.13.